Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026 MELBOURNE, AUSTRALIA AND SAN FRANCISCO, USA – 3 September 2026: Alterity Therapeutics (ASX: ATH, NASDAQ: ATHE) (“Alterity” or “the Company”), a biotechnology company...
Alterity to Present at Cantor Global Healthcare Conference
Filed with ASX · · 2 pages · English
Summary by 6ix AI
Alterity Therapeutics announced its participation in a Fireside Chat at the Cantor Global Healthcare Conference. David Stamler, the CEO, will speak at the event scheduled for a specific time in the United States. The company focuses on developing treatments for neurodegenerative diseases, particularly Multiple System Atrophy.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Release
Alterity Therapeutics Ltd. on 6ix
Story so far
Earlier from Alterity Therapeutics
- Change of Director's Interest Notice - Stamler
- Change of Director's Interest Notice - Marks
- Application for quotation of securities - ATH
- Alterity Therapeutics Filed Form 20-F and XBRL Data with SEC
- $4.2M Options Underwriting Agreement Executed
Later from Alterity Therapeutics
- Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
- Cleansing Notice Under Section 708A
- Alterity Therapeutics to Present at ASX SMIDcaps Conference
- Corporate Presentation September 2026
- Date of AGM and Closing Date for Director Nominations
Follow Alterity Therapeutics into a list and get an email when it puts out news.
Follow Alterity Therapeutics